Neuren Pharmaceuticals Ltd. (NURPF)
14.28
+0.34
(+2.42%)
USD |
OTCM |
Oct 02, 16:00
Neuren Pharmaceuticals Price : 14.28 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 400.00 |
| Oct 01, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 30, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 29, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 28, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 25, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 24, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 23, 2026 | 15.00 | 15.00 | 13.94 | 13.94 | 530.00 |
| Sep 22, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 100.00 |
| Sep 21, 2026 | 15.76 | 15.76 | 15.76 | 15.76 | 0.000 |
| Sep 18, 2026 | 15.76 | 15.76 | 15.76 | 15.76 | 0.000 |
| Sep 17, 2026 | 15.76 | 15.76 | 15.76 | 15.76 | 0.000 |
| Sep 16, 2026 | 15.76 | 15.76 | 15.76 | 15.76 | 0.000 |
| Sep 15, 2026 | 16.10 | 16.10 | 15.76 | 15.76 | 400.00 |
| Sep 14, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 11, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 10, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 09, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 08, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 04, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 03, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 0.000 |
| Sep 02, 2026 | 16.10 | 16.10 | 16.10 | 16.10 | 100.00 |
| Sep 01, 2026 | 16.01 | 16.01 | 16.01 | 16.01 | 0.000 |
| Aug 31, 2026 | 15.01 | 16.01 | 15.01 | 16.01 | 300.00 |
| Aug 28, 2026 | 16.24 | 16.24 | 16.24 | 16.24 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Percheron Therapeutics Ltd. | 0.0024 |
| Starpharma Holdings Ltd. | 5.05 |
| Mayne Pharma Group Ltd. | 2.00 |
| Acrux Ltd. | 0.0033 |
| Zelira Therapeutics Ltd. | 0.26 |
Price Related Metrics
| PE Ratio | 138.61 |
| PS Ratio | 39.35 |
| Price to Free Cash Flow | 290.42 |
| Earnings Yield | 0.72% |
| Market Cap | 1.810B |
| Operating PE Ratio | 201.49 |
| Normalized PE Ratio | 115.60 |